MetricSide LogoMetricSide
Learn
  1. Home
  2. Companies
  3. Healthcare
  4. XENE
OverviewMetricsPricesRevenue & ProfitAssets & LiabilitiesCash FlowMarginsPrice RatiosOthers
MetricSide

Standardized stock fundamentals and valuation metrics. Analyze revenue, EBITDA, free cash flow, and more with interactive charts.

Stock Sectors

  • Technology
  • Healthcare
  • Financials
  • Consumer
  • Industrials
  • Energy
  • Real Estate
  • Materials

Legal & Contact

  • Terms of Service
  • Privacy Policy
  • Contact Us
Not Financial Advice: MetricSide is a data aggregation and visualization tool. Nothing on this website constitutes investment advice, a recommendation, or a solicitation to buy or sell any security. All data is provided for informational and educational purposes only. Past performance is not indicative of future results. Always consult a qualified financial professional before making investment decisions. Data accuracy is not guaranteed — verify critical information against official sources.

© 2026 MetricSide. All rights reserved.

Xenon Pharmaceuticals (XENE) Revenue & Earnings 2020-2026

Revenue, EBITDA, operating income, net income, EPS, and shares

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares across quarters

TTM Revenue
$0
100.0%
Q. Revenue
$0
TTM EBITDA
$-408.92M
41.5%
TTM Op. Income
$-412.66M
40.8%
Q. Op. Income
$-112.33M
TTM Net Income
$-383.17M
52.4%
Q. Net Income
$-102.30M
EPS
$-1.17
Shares Out.
$87.35M
11.0%
$0 in TTM revenue declined 100.0% YoY, reaching $0 last quarter. TTM EBITDA of $-408.92M and TTM operating income of $-412.66M shows growth is flowing through. However, net income is negative at $383.17M — growth is not yet reaching the bottom line. Revenue is contracting — assess whether this is cyclical or structural.
TTM Revenue
Reveals whether the core business is growing or shrinking
Quarterly Revenue
Highlights seasonal patterns and short-term momentum
TTM EBITDA
Shows if underlying operating profitability is improving
Quarterly EBITDA
Tracks near-term operating profitability trends
TTM Operating Income
Smoothed operating profit over the past four quarters
Quarterly Operating Income
Profit from core operations before financing costs
TTM Net Income
The bottom line — is the company making more money?
Quarterly Net Income
Short-term profit after all expenses and taxes
EPS
Earnings per share — profit attributable to each share
Shares Outstanding
Declining means buybacks benefit remaining holders